Botulinum toxin type A selectivity for certain types of pain is associated with capsaicin-sensitive neurons

Pain

Volumn 155, Issue 8, 2014, Pages 1516-1526

  Matak, Ivica ^a   Rossetto, Ornella ^b   Lacković, Zdravko ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Axonal transport; Botulinum toxin type A; Central afferent terminals; Pain; Trigeminal nucleus caudalis; TRPV1 expressing neurons

Indexed keywords

BOTULINUM TOXIN A; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; VANILLOID RECEPTOR 1; PROTEIN C FOS; TRPV1 PROTEIN, RAT; VANILLOID RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; AVERSION THERAPY; CENTRAL NUCLEUS (AMYGDALA); COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA REFLEX; DENERVATION; ENZYME ACTIVITY; FORMALIN TEST; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOCUS CERULEUS; MALE; MECHANICAL STIMULATION; NERVE CELL; NERVE FIBER TRANSPORT; NONHUMAN; ONCOGENE C FOS; PAIN; PAIN THRESHOLD; PARAVENTRICULAR THALAMIC NUCLEUS; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; TRIGEMINAL NERVE; TRIGEMINAL NUCLEUS; TRIGEMINAL NUCLEUS CAUDALIS; TRIGEMINUS GANGLION; ANIMAL; DRUG EFFECTS; METABOLISM; WISTAR RAT;

ANIMALS; BOTULINUM TOXINS, TYPE A; CAPSAICIN; MALE; PAIN; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; SENSORY RECEPTOR CELLS; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TRIGEMINAL GANGLION; TRPV CATION CHANNELS;

EID: 84904569416     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2014.04.027     Document Type: Article

References (71)

1. N. Akaike, M.C. Shin, M. Wakita, Y. Torii, T. Harakawa, A. Ginnaga, K. Kato, R. Kaji, and S. Kozaki Transsynaptic inhibition of spinal transmission by A2 botulinum toxin J Physiol 591 2013 1031 1043
2. K.R. Aoki Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A Neurotoxicology 26 2005 785 793
3. A. Apostolidis, R. Popat, Y. Yiangou, D. Cockayne, A.P. Ford, J.B. Davis, P. Dasqupta, C.J. Fowler, and P. Anland Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity J Urol 174 2005 977 982
4. L. Bach-Rojecky, M. Dominis, and Z. Lacković Lack of anti-inflammatory effects of botulinum toxin A in experimental models of inflammation Fundam Clin Pharmacol 22 2008 503 509
5. L. Bach-Rojecky, and Z. Lacković Antinociceptive effect of botulinum toxin type A in rat model of carrageenan and capsaicin induced pain Croat Med J 46 2005 201 208
6. L. Bach-Rojecky, and Z. Lacković Central origin of the antinociceptive action of botulinum toxin type A Pharmacol Biochem Behav 94 2009 234 238
7. L. Bach-Rojecky, M. Relja, and Z. Lacković Botulinum toxin type A in experimental neuropathic pain J Neural Transm 112 2005 215 219
8. L. Bach-Rojecky, M. Šalković-Petrišić, and Z. Lacković Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effects after unilateral injection Eur J Pharmacol 633 2010 10 14
9. Y.C. Bae, J.M. Oh, S.J. Hwang, Y. Shigenaga, and J.G. Valtschanoff Expression of vanilloid receptor TRPV1 in the rat trigeminal sensory nuclei J Comp Neurol 478 2004 62 71
10. M.R. Baldwin, and J.T. Barbieri Association of botulinum neurotoxins with synaptic vesicle protein complexes Toxicon 54 2009 570 574
11. J. Baulmann, H. Spitznagel, T. Herdegen, T. Unger, and J. Culman Tachykinin receptor inhibition and c-Fos expression in the rat brain following formalin-induced pain Neuroscience 95 2000 813 820
12. M. Bishnoi, C.A. Bosgraaf, and L.S. Premkumar Preservation of acute pain and efferent functions following intrathecal resiniferatoxin-induced analgesia in rats J Pain 12 2011 991 1003
13. J. Blasi, E.R. Chapman, E. Link, T. Binz, S. Yamasaki, P. De Camilli, T.C. Sudhof, H. Niemann, and R. Jahn Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25 Nature 365 1993 160 163
14. W. Blersch, W.J. Schulte-Mattler, S. Przywara, A. May, H. Bigalke, and K. Wohlfarth Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study J Neurol Sci 205 2002 59 63
15. L.S. Cruz, C.M. Kopruszinski, and J.G. Chichorro Intraganglionar resiniferatoxin prevents orofacial inflammatory and neuropathic hyperalgesia Behav Pharmacol 25 2014 112 118
16. M. Cui, S. Khanijou, J. Rubino, and K.R. Aoki Subcutaneous administration of botulinum toxin A reduces formalin-induced pain PAIN® 107 2004 125 133
17. D.V. Dodick, C.C. Turkel, R.E. DeGryse, S.K. Aurora, S.D. Silberstein, R.B. Lipton, H.C. Deiner, M.F. Brin PREEMPT Chronic Migraine Study Group Onabotulinumtoxin A for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT Clinical Program Headache 50 2010 921 936
18. V. Drinovac, L. Bach-Rojecky, I. Matak, and Z. Lacković Involvement of the μ-opioid receptors in the antinociceptive activity of botulinum toxin A Neuropharmacology 70 2013 331 337
19. P.L. Durham, and R. Cady Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy Headache 44 2004 35 42
20. C. Favre-Guilmard, M. Auguet, and P.E. Chabrier Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models Eur J Pharmacol 617 2009 48 53
21. B. Filipović, I. Matak, L. Bach-Rojecky, and Z. Lacković Central action of peripherally applied botulinum toxin type a on pain and dural protein extravasation in rat model of trigeminal neuropathy PLoS One 7 2012 e29803
22. A. Franco-Cereceda, H. Henke, J.M. Lundberg, J.B. Petermann, T. Hökfelt, and J.A. Fischer Calcitonin gene-related peptide (CGRP) in capsaicin-sensitive substance P-immunoreactive sensory neurons in animals and man: distribution and release by capsaicin Peptides 8 1987 399 410
23. B. Freund, and M. Schwartz Temporal relationship of muscle weakness and pain reduction in subjects treated with botulinum toxin A J Pain 4 2003 159 165
24. P. Gazerani, N.S. Pedersen, C. Staahl, A.M. Drewes, and L. Arendt-Nielsen Subcutaneous botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin PAIN® 141 2009 60 69
25. S.J. Gibson, J.M. Polak, S.R. Bloom, I.M. Sabate, P.M. Mulderry, M.A. Ghatei, G.P. McGregor, J.F. Morrison, J.S. Kelly, R.M. Evans, and M.G. Rosenfeld Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species J Neurosci 4 1984 3101 3111
26. S.J. Hwang, A. Burette, A. Rustioni, and J.G. Valtschanoff Vanilloid receptor VR1-positive primary afferents are glutamatergic and contact spinal neurons that co-express neurokinin receptor NK1 and glutamate receptors J Neurocytol 33 2004 321 329
27. S.J. Hwang, and J.G. Valtschanoff Vanilloid receptor VR1-positive afferents are distributed differently at different levels of the rat lumbar spinal cord Neurosci Lett 349 2003 41 44
28. H. Ichikawa, and T. Sugimoto VR1-immunoreactive primary sensory neurons in the rat trigeminal ganglion Brain Res 890 2001 184 188
29. H. Ishikawa, Y. Mitsui, T. Yoshitomi, K. Mashimo, S. Aoki, K. Mukuno, and K. Shimizu Presynaptic effects of botulinum toxin type A on the neuronally evoked responses of albino and pigmented iris sphincter and dilator muscles Jpn J Ophthalmol 44 2000 106 109
30. B. Jabbari, and D. Machado Treatment of refractory pain with botulinum toxins-an evidence-based review Pain Med 12 2011 1594 1606
31. R. Jahn, and D. Fasshauer Molecular machines governing exocytosis of synaptic vesicles Nature 490 2012 201 207
32. J.A. Jeffry, S.Q. Yu, P. Sikand, A. Parihar, M.S. Evans, and L.S. Premkumar Selective targeting of TRPV1 expressing sensory nerve terminals in the spinal cord for long lasting analgesia PLoS One 4 2009 e7021
33. Y. Kanai, T. Hara, and A. Imai Participation of the spinal TRPV1 receptors in formalin-evoked pain transduction: a study using a selective TRPV1 antagonist, iodo-resiniferatoxin J Pharm Pharmacol 58 2006 489 493
34. Y. Kanai, E. Nakazato, A. Fujiuchi, T. Hara, and A. Imai Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats Neuropharmacology 49 2005 977 984
35. T. King, C. Qu, A. Okun, R. Mercado, J. Ren, T. Brion, J. Lai, and F. Porreca Contribution of afferent pathways to nerve injury-induced spontaneous pain and evoked hypersensitivity PAIN® 152 2011 1997 2005
36. I. Kissin, C.F. Freitas, and E.L. Bradley Jr. Perineural resiniferatoxin prevents the development of hyperalgesia produced by loose ligation of the sciatic nerve in rats Anesth Analg 104 2007 1210 1216
37. S. Marinelli, V. Vacca, R. Ricordy, C. Uggenti, A.M. Tata, S. Luvisetto, and F. Pavone The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes PLoS One 7 2012 e47977
38. M.J. Marino, T. Terashima, J.J. Steinauer, K.A. Eddinger, T.L. Yaksh, and Q. Xu Botulinum toxin B in the sensory afferent: transmitter release, spinal activation and pain behavior PAIN® 155 2013 674 684
39. I. Matak, L. Bach-Rojecky, B. Filipović, and Z. Lacković Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A Neuroscience 186 2011 201 207
40. I. Matak, P. Riederer, and Z. Lacković Botulinum toxin's axonal transport from periphery to the spinal cord Neurochem Int 61 2012 236 239
41. I. Matak, I. Stracenski, and Z. Lacković Comparison of analgesic effects of single versus repeated injection of botulinum toxin in orofacial formalin test in rats J Neural Transm 120 2013 141 144
42. S.B. McMahon, P.D. Wall, S.L. Granum, and K.E. Webster The effects of capsaicin applied to peripheral nerves on responses of a group of lamina I cells in adult rats J Comp Neurol 227 1984 393 400
43. S.K. Mishra, and M.A. Hoon Ablation of TrpV1 neurons reveals their selective role in thermal pain sensation Mol Cell Neurosci 43 2010 157 163
44. J.K. Neubert, A.J. Mannes, L.J. Karai, A.C. Jenkins, L. Zawatski, M. Abu-Asab, and M.J. Iadarola Perineural resiniferatoxin selectively inhibits inflammatory hyperalgesia Mol Pain 4 2008 3
45. J.K. Neubert, A.J. Mannes, J. Keller, M. Wexel, M.J. Iadarola, and R.M. Caudle Peripheral targeting of the trigeminal ganglion via the infraorbital foramen as a therapeutic strategy Brain Res Prot 15 2005 119 126
46. H.J. Park, Y. Lee, J. Lee, C. Park, and D.E. Moon The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain Can J Anaesth 53 2006 470 477
47. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 5th ed. 2005 Elsevier Academic Burlington, MA
48. D. Pirici, L. Mogoanta, S. Kumar-Singh, I. Pirici, C. Margaritescu, C. Simionescu, and R. Stanescu Antibody elution method for multiple immunohistochemistry on primary antibodies raised in the same species and of the same subtype J Histochem Cytochem 57 2009 567 575
49. J.D. Pomonis, J.E. Harrison, L. Mark, D.R. Bristol, K.J. Valenzano, and K. Walker N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine- 1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. In vivo characterization in rat models of inflammatory and neuropathic pain J Pharmacol Exp Ther 306 2003 387 393
50. T.J. Price, and C.M. Flores Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1 immunoreactivities, and isolectin B4 binding in primary afferent neurons of the rat and mouse J Pain 8 2007 263 272
51. P. Raboisson, and R. Dallel The orofacial formalin test Neurosci Biobehav Rev 28 2004 219 226
52. L. Restani, F. Antonucci, L. Gianfranceschi, C. Rossi, O. Rossetto, and M. Caleo Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT/A) J Neurosci 31 2011 15650 15659
53. L. Restani, E. Novelli, D. Bottari, P. Leone, I. Barone, L. Galli-Resta, E. Strettoi, and M. Caleo Botulinum neurotoxin A impairs neurotransmission following retrograde transynaptic transport Traffic 13 2012 1083 1089
54. S.D. Shields, D.J. Cavanaugh, H. Lee, D.J. Anderson, and A.I. Basbaum Pain behavior in the formalin test persists after denervation of the great majority of C-fiber nociceptors PAIN® 151 2010 422 429
55. T. Shimizu, M. Shibata, H. Toriumi, T. Iwashita, M. Funakubo, H. Sato, T. Kuroi, T. Ebine, K. Koizumi, and N. Suzuki Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A Neurobiol Dis 48 2012 367 378
56. Y. Sugimoto, Y. Kojima, A. Inayoshi, K. Inoue, H. Miura-Kusaka, K. Mori, O. Saku, H. Ishida, E. Atsumi, Y. Nakasato, S. Shirakura, S. Toki, K. Shinoda, and N. Suzuki K-685, a TRPV1 antagonist, blocks PKC-sensitized TRPV1 activation and improves the inflammatory pain in a rat complete Freund's adjuvant model J Pharmacol Sci 123 2013 256 266
57. B. Szende, and E. Tyihák Effect of formaldehyde on cell proliferation and death Cell Biol Int 34 2010 1273 1282
58. J. Szolcsányi, and E. Pintér Transient receptor potential vanilloid 1 as a therapeutic target in analgesia Expert Opin Ther Targets 17 2013 641 657
59. L. Tang, Y. Chen, Z. Chen, P.M. Blumberg, A.P. Kozikowski, and Z.J. Wang Antinociceptive pharmacology of N-(4-chlorobenzyl)-N′-(4-hydroxy-3-iodo-5- methoxybenzyl) thiourea, a high-affinity competitive antagonist of the transient receptor potential vanilloid 1 receptor J Pharmacol Exp Ther 321 2007 791 798
60. G.C. Tender, Y.Y. Li, and J.G. Cui Vanilloid receptor 1-positive neurons mediate thermal hyperalgesia and tactile allodynia Spine J 8 2008 351 358
61. A. Thyssen, D. Hirnet, H. Wolburg, G. Schmalzing, J.W. Deitmer, and C. Lohr Ectopic vesicular neurotransmitter release along sensory axons mediates neurovascular coupling via glial calcium signaling Proc Natl Acad Sci U S A 107 2010 15258 15263
62. A.J. Todd Neuronal circuitry for pain processing in the dorsal horn Nat Rev Neurosci 11 2010 823 836
63. V. Vacca, S. Marinelli, C. Eleuteri, S. Luvisetto, and F. Pavone Botulinum neurotoxin A enhances the analgesic effects on inflammatory pain and antagonizes tolerance induced by morphine in mice Brain Behav Immun 26 2012 489 499
64. V.M. Vemulakonda, G.T. Somogyi, S. Kiss, N.A. Salas, T.B. Boone, and C.P. Smith Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation J Urol 173 2005 621 624
65. B.P. Vos, A.M. Strassman, and R.J. Maciewicz Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve J Neurosci 14 1994 2708 2723
66. T. Watabiki, T. Kiso, T. Kuramochi, K. Yonezawa, N. Tsuji, A. Kohara, S. Kakimoto, T. Aoki, and N. Matsuoka Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect J Pharmacol Exp Ther 336 2011 743 750
67. C.J. Wu, Y.J. Lian, Y.K. Zheng, H.F. Zhang, Y. Chen, N.C. Xie, and L.J. Wang Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial Cephalalgia 32 2012 443 450
68. L. Xiao, J. Cheng, J. Dai, and D. Zhang Botulinum toxin decreases hyperalgesia and inhibits P2X3 receptor over-expression in sensory neurons induced by ventral root transection in rats Pain Med 12 2011 1385 1394
69. L. Xiao, J. Cheng, Y. Zhuang, W. Qu, J. Muir, H. Liang, and D. Zhang Botulinum toxin type A reduces hyperalgesia and TRPV1 expression in rats with neuropathic pain Pain Med 14 2013 276 286
70. Y. Yiangou, U. Anand, W.R. Otto, M. Sinisi, M. Fox, R. Birch, K.A. Foster, G. Mukerji, A. Akbar, S.K. Agarwal, and P. Anand Increased levels of SV2A botulinum neurotoxin receptor in clinical sensory disorders and functional effects of botulinum toxins A and E in cultured human sensory neurons J Pain Res 4 2011 347 355
71. M. Zimmerman Ethical guidelines for investigations of experimental pain in conscious animals PAIN® 16 1983 109 110